About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
78 genotypes with 78 annotations displayed of selected term and subterms
Searched Term: decreased susceptibility to type IV hypersensitivity reaction
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Ahrtm1Bra/Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:148870
Anxa5tm1Epo/Anxa5tm1Epo
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:117249
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J) 		decreased susceptibility to type IV hypersensitivity reaction J:61564
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:106669
B4gat1tm1Mifu/B4gat1tm1Mifu
Gcnt1tm1Jxm/Gcnt1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:120722
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:45920
Ccl5tm1Hso/Ccl5tm1Hso
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:75842
Ccl17tm1.1Ifo/Ccl17tm1.1Ifo
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:159098
Ccr7tm1Rfor/Ccr7tm1Rfor
(involves: 129P2/OlaHsd * BALB/c) 		decreased susceptibility to type IV hypersensitivity reaction J:57976
Cd28tm1Pjl/Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:83722
Cd28tm1Pjl/Cd28tm1Pjl
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk) 		decreased susceptibility to type IV hypersensitivity reaction J:83722
Cd44tm2Kmz/Cd44tm2Kmz
(involves: BALB/c * DBA/1) 		decreased susceptibility to type IV hypersensitivity reaction J:114317
Cd44tm2Kmz/Cd44tm2Kmz
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * BALB/c * DBA/1) 		decreased susceptibility to type IV hypersensitivity reaction J:114317
Cd74tm1Liz/Cd74tm1Liz
(B6.129S-Cd74tm1Liz) 		decreased susceptibility to type IV hypersensitivity reaction J:125654
Cd83lcd4/Cd83lcd4
(involves: C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:92721
Cd83tm1Tft/Cd83tm1Tft
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:75700
Cd99l2tm1.1Dvst/Cd99l2tm1.1Dvst
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:193021
Cd207tm1(Hbegf/EGFP)Bjec/Cd207+
(involves: C57BL/6 * SJL) 		decreased susceptibility to type IV hypersensitivity reaction J:137517
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1) 		decreased susceptibility to type IV hypersensitivity reaction J:25215
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:203159
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to type IV hypersensitivity reaction J:203159
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Dran Il3tm1Glli) 		decreased susceptibility to type IV hypersensitivity reaction J:67404
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli
(C.129S2-Csf2tm1Dran Il3tm1Glli) 		decreased susceptibility to type IV hypersensitivity reaction J:67404
Cxcl10tm1Adl/Cxcl10tm1Adl
(involves: 129S4/SvJae * 129X1/SvJ) 		decreased susceptibility to type IV hypersensitivity reaction J:75584
Eef1a2wst/Eef1a2wst
(B6C3Fe a/a-Eef1a2wst/J) 		decreased susceptibility to type IV hypersensitivity reaction J:6766
Ephb6tm1Jwu/Ephb6tm1Jwu
(involves: 129) 		decreased susceptibility to type IV hypersensitivity reaction J:94701
F2rl1tm1Jkaw/F2rl1tm1Jkaw
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:106127
Fcer1gtm1Tks/Fcer1gtm1Tks
(involves: C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:112160
Fut4tm1Jbl/Fut4tm1Jbl
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl Fut4tm1Jbl) 		decreased susceptibility to type IV hypersensitivity reaction J:79388
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl) 		decreased susceptibility to type IV hypersensitivity reaction J:79388, J:74776
H2-DMatm1Luc/H2-DMatm1Luc
(B6.129S4-H2-Dmatm1Luc) 		decreased susceptibility to type IV hypersensitivity reaction J:125654
Icam1tm1Bay/Icam1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:14565
Icam1tm1Jcgr/Icam1tm1Jcgr
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		decreased susceptibility to type IV hypersensitivity reaction J:18743
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		decreased susceptibility to type IV hypersensitivity reaction J:211949
Ido2em1Lamn/Ido2em1Lamn
(involves: BALB/c * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:342726
Ido2em2Lamn/Ido2em2Lamn
(involves: BALB/c * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:342726
Ido2tm1.2Gcp/Ido2tm1.2Gcp
(involves: C57BL/6J * FVB/N) 		decreased susceptibility to type IV hypersensitivity reaction J:211949
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd) 		decreased susceptibility to type IV hypersensitivity reaction J:29170
Ifngr2tm1Pbro/Ifngr2tm1Pbro
(involves: 129S1/Sv) 		decreased susceptibility to type IV hypersensitivity reaction J:48016
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas) 		decreased susceptibility to type IV hypersensitivity reaction J:112160
Il1atm1Yiw/Il1atm1Yiw
Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:165513
Il1btm1Dch/Il1btm1Dch
(involves: 129S2/SvPas) 		decreased susceptibility to type IV hypersensitivity reaction J:33465
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:42373
Il3tm1Glli/Il3tm1Glli
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6)) 		decreased susceptibility to type IV hypersensitivity reaction J:80640
Il12atm1Jm/Il12atm1Jm
(129S1/Sv-Il12atm1Jm) 		decreased susceptibility to type IV hypersensitivity reaction J:34164
Il12btm1Jm/Il12btm1Jm
(B6.129S1-Il12btm1Jm/J) 		decreased susceptibility to type IV hypersensitivity reaction J:120806
Il12btm1Jm/Il12btm1Jm
(129S1/Sv-Il12btm1Jm) 		decreased susceptibility to type IV hypersensitivity reaction J:34164
Il15tm1Imx/Il15tm1Imx
(involves: C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:87137
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:79127
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J) 		decreased susceptibility to type IV hypersensitivity reaction J:79127
Il21rtm1Day/Il21rtm1Day
(involves: BALB/c * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:144708
Il34tm1b(EUCOMM)Wtsi/Il34tm1b(EUCOMM)Wtsi
(involves: BALB/cJ * C57BL/6N) 		decreased susceptibility to type IV hypersensitivity reaction J:187643
Itgb2tm2Bay/Itgb2tm2Bay
(PL.129S7-Itgb2tm2Bay) 		decreased susceptibility to type IV hypersensitivity reaction J:109598
Mmp3tm1Mrl/Mmp3tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/10ScSn * RIII) 		decreased susceptibility to type IV hypersensitivity reaction J:55723
Mmp19tm1Rase/Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase) 		decreased susceptibility to type IV hypersensitivity reaction J:137128
Nlrp3tm1Flv/Nlrp3tm1Flv
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:113333
Nlrp12tm1Jpyt/Nlrp12tm1Jpyt
(B6.Cg-Nlrp12tm1Jpyt) 		decreased susceptibility to type IV hypersensitivity reaction J:164725
Npy1rtm1.1Wpg/Npy1rtm1.1Wpg
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:118850
Pgftm1Pec/Pgftm1Pec
(involves: 129) 		decreased susceptibility to type IV hypersensitivity reaction J:81388
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(C.129-Ptgdr2tm1Tasa) 		decreased susceptibility to type IV hypersensitivity reaction J:131146
Ptger1tm1Sna/Ptger1tm1Sna
(B6CrSlc.129P2-Ptger1tm1Sna/Sna) 		decreased susceptibility to type IV hypersensitivity reaction J:128435
Ptger4tm1Sna/Ptger4tm1Sna
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:83725
Pycardtm1Flv/Pycardtm1Flv
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:113333
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:165513
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:22675
Sbsnem1Ham/Sbsnem1Ham
(C57BL/6N-Sbsnem1Ham) 		decreased susceptibility to type IV hypersensitivity reaction J:296400
Selptm1Bay/Selptm1Bay
(B6.129S7-Selptm1Bay) 		decreased susceptibility to type IV hypersensitivity reaction J:121083
Sema4atm1Kik/Sema4atm1Kik
(either: B6.Cg-Sema4atm1Kik or C.Cg-Sema4atm1Kik) 		decreased susceptibility to type IV hypersensitivity reaction J:97027
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:60284
Tg(CD2-Ifngr2)1Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)1Pbro) 		decreased susceptibility to type IV hypersensitivity reaction J:134448
Tg(CD2-S1PR1)1Ejg/?
(involves: C57BL/6 * DBA/2) 		decreased susceptibility to type IV hypersensitivity reaction J:96558
Tg(LCK-NFKBIA)5Dwb/?
(involves: BALB/c * C57BL/6 * DBA/2) 		decreased susceptibility to type IV hypersensitivity reaction J:145531
Tg(Lck-VIPR2)1Ejg/0
(C57BL/6-Tg(Lck-VIPR2)1Ejg) 		decreased susceptibility to type IV hypersensitivity reaction J:127974
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:47673
Tnfsf4tm1Shr/Tnfsf4tm1Shr
(involves: 129S4/SvJae) 		decreased susceptibility to type IV hypersensitivity reaction J:59203
Tnfsf4tm1Sug/Tnfsf4tm1Sug
(B6.129S4-Tnfsf4tm1Sug) 		decreased susceptibility to type IV hypersensitivity reaction J:80214
Trip10tm1.1Geha/Trip10tm1.1Geha
(B6.129S1-Trip10tm1.1Geha) 		decreased susceptibility to type IV hypersensitivity reaction J:164363
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		decreased susceptibility to type IV hypersensitivity reaction J:64764
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/30/2024
MGI 6.23 		The Jackson Laboratory